Literature DB >> 7082332

Inactivation of prostaglandins in the perfused rat lung.

C Robinson, J R Hoult.   

Abstract

Inactivation in the isolated perfused rat lung of prostaglandins (PG) D2, E1, F2 alpha, I2 and the metabolites 6-keto PGF1 alpha (=6KF1 alpha) and 13, 14-dihydro-15-keto PGF2 alpha (= KH2F2 alpha) was studied using 5 min perfusion of 7-10 ng/ml PG in Krebs' solution containing 0.02 microCi/ml tritiated PG and 4.5% bovine serum albumin (BSA). The parameters measured were (a) extent of inactivation (F2 alpha greater than E1 greater than D2 greater than 6KF1 alpha greater than I2; KH2F2 alpha unchanged), (b) the accumulation of PG within the lung measured as tissue to medium ratio (F2 alpha = D2 greater than E1 greater than 6KF1 alpha greater than I1 - KH2F2 alpha) and (c) rate of equilibration of PG within the lung measured as "wash-in t 1/2" (D2 greater than F2 alpha greater than E1 greater than I2 = 6KF1 alpha = KH2F2 alpha). Removal of sodium ions produced a small decrease in PGD2 and PGE1 breakdown but not of PGF2 alpha whereas breakdown of all PGs was markedly inhibited at 5 degrees. Removal of BSA enhanced PGE1 and PGI2 breakdown but not that of PGF2 alpha. Addition of 10% BSA inhibited PGE1 breakdown but not that of PGF2 alpha. Binding of PGs to 4.5% BSA was PGE1 = KH2F2 alpha greater than D2 greater than F2 alpha, and increased at 10% BSA or after removal of sodium ions. These data support the view that PGs must be taken up into pulmonary cells by a transmembrane carrier process as a prerequisite for enzymatic breakdown. The metabolites are then released back into the pulmonary circulation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7082332     DOI: 10.1016/0006-2952(82)90442-7

Source DB:  PubMed          Journal:  Biochem Pharmacol        ISSN: 0006-2952            Impact factor:   5.858


  5 in total

1.  Selective inhibition of thromboxane B2 accumulation and metabolism in perfused guinea-pig lung.

Authors:  J R Hoult; C Robinson
Journal:  Br J Pharmacol       Date:  1983-01       Impact factor: 8.739

2.  Effect of sulphasalazine on pulmonary inactivation of prostaglandin F2 alpha in the pig.

Authors:  P G Hellewell; J D Pearson
Journal:  Br J Pharmacol       Date:  1982-06       Impact factor: 8.739

3.  Evidence against the formation of 13,14-dihydro-15-keto-prostaglandin F2 alpha following inhalation of prostaglandin D2 in man.

Authors:  C C Hardy; S T Holgate; C Robinson
Journal:  Br J Pharmacol       Date:  1986-03       Impact factor: 8.739

4.  Release of arachidonic acid metabolites and histamine from sensitized guinea-pig lung following antigen challenge.

Authors:  N C Turner; C T Dollery
Journal:  Br J Pharmacol       Date:  1988-04       Impact factor: 8.739

5.  Increases in plasma concentrations of a prostaglandin metabolite in acute airway obstruction.

Authors:  D P Skoner; P Fireman; H W Davis; R Wall; L A Caliguiri
Journal:  Arch Dis Child       Date:  1989-08       Impact factor: 3.791

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.